|
ALS2CR4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.397800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.475800E-02 |
| Normal-vs-Stage2 |
2.182900E-03 |
| Normal-vs-Stage3 |
1.053160E-01 |
| Normal-vs-Stage4 |
2.016200E-01 |
| Stage1-vs-Stage2 |
3.051700E-02 |
| Stage1-vs-Stage3 |
8.386800E-01 |
| Stage1-vs-Stage4 |
9.105800E-01 |
| Stage2-vs-Stage3 |
5.611800E-02 |
| Stage2-vs-Stage4 |
5.157900E-02 |
| Stage3-vs-Stage4 |
7.930200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.371440E-01 |
| Normal-vs-AfricanAmerican |
9.448600E-01 |
| Normal-vs-Asian |
7.127800E-01 |
| Caucasian-vs-AfricanAmerican |
3.367600E-01 |
| Caucasian-vs-Asian |
3.428800E-01 |
| AfricanAmerican-vs-Asian |
8.338800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.264700E-03 |
| Normal-vs-Female |
1.451550E-01 |
| Male-vs-Female |
8.400100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.655600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.538200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.680500E-03 |
| Normal-vs-Age(81-100Yrs) |
4.237600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.216780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.170000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.828600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.960000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.211800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.312600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.442400E-01 |
| Classical-VS-Follicular |
5.04041253179821E-14 |
| Classical-VS-Other |
2.186400E-01 |
| Classical-VS-Normal |
6.833200E-01 |
| Tall-VS-Follicular |
7.60399998522843E-09 |
| Tall-VS-Other |
6.449500E-02 |
| Tall-VS-Normal |
5.564200E-01 |
| Follicular-VS-Other |
1.700020E-01 |
| Follicular-VS-Normal |
2.24490004363531E-09 |
| Other-VS-Normal |
1.434770E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.478840E-03 |
| Normal-vs-N1 |
2.265000E-01 |
| N0-vs-N1 |
1.345200E-01 |
|
|
